Korean J Fam Med > Epub ahead of print |
|
Characteristic | Total (n=8,748) | CAG (n=3,076) | Non-CAG (n=5,672) | P-value |
---|---|---|---|---|
Age (y) | 59.61±8.03 | 62.63±7.89 | 57.97±7.61 | <0.001 |
Body mass index (kg/m2) | 23.07±3.13 | 23.25±3.10 | 22.97±3.14 | <0.001 |
Waist circumference (cm) | 81.59±8.65 | 82.40±8.53 | 81.15±8.68 | <0.001 |
Hypertension* | 3,038 (34.73) | 1,209 (39.30) | 1,829 (32.25) | <0.001 |
Dyslipidemia† | 4,418 (50.50) | 1,630 (52.99) | 2,788 (49.15) | 0.001 |
Diabetes mellitus‡ | 1,435 (16.40) | 586 (19.05) | 849 (14.97) | <0.001 |
Chronic kidney disease§ | 441 (5.04) | 185 (6.01) | 256 (4.51) | 0.002 |
Thyroid disease∥ | 1,427 (16.31) | 539 (17.52) | 888 (15.66) | 0.024 |
Current smoking¶ | 215 (2.46) | 51 (1.66) | 164 (2.89) | <0.001 |
Current drinking# | 122 (1.39) | 52 (1.69) | 70 (1.23) | 0.025 |
Moderate to severe physical activity** | 545 (6.23) | 185 (6.01) | 360 (6.35) | 0.825 |
Menopause†† | 6,835 (78.13) | 2,524 (82.05) | 4,311 (84.46) | <0.001 |
Hormone replace therapy‡‡ | 1,282 (16.43) | 488 (18.03) | 794 (15.58) | <0.001 |
L1–L4 BMD (g/cm2) | 1.070±0.160 | 1.044±0.157 | 1.084±0.160 | <0.001 |
Femur neck BMD (g/cm2) | 0.833±0.116 | 0.810±0.111 | 0.845±0.118 | <0.001 |
Femur total BMD (g/cm2) | 0.896±0.123 | 0.876±0.120 | 0.906±0.124 | <0.001 |
Low BMD§§ | 4,164 (47.60) | 1,747 (56.79) | 2,417 (42.61) | <0.001 |
Values are presented as mean±standard deviation or number (%). P-values were calculated using the independent t-test for continuous outcomes and χ2-test for discrete outcomes.
CAG, chronic atrophic gastritis; BMD, bone mineral density; CKD, chronic kidney disease; TSH, thyroid-stimulating hormone.
* Those who had a history of hypertension or taking hypertensive medications or systolic blood pressure ≥140 mm Hg.
† Those who had history of dyslipidemia or taking medications or total cholesterol ≥240 mg/dL or low-density lipoprotein ≥160 mg/dL or triglyceride ≥200 mg/dL or high-density lipoprotein <40 mg/dL.
‡ Those who had a history of diabetes mellitus or taking diabetes medications or glycated hemoglobin ≥6.5% or fasting blood sugar ≥126 mg/dL.
§ Those who had a history of CKD or taking medications due to CKD or calculated glomerular filtration rate using the Modification of Diet in Renal Diseases equation <60 mL/min.
∥ Those who had a history of hypothyroidism or hyperthyroidism or taking medications for thyroid dysfunction or TSH <0.35 mIU/L or TSH >4.94 mIU/L.
Variable | Odds ratio (95% CI) | P-value |
---|---|---|
Total | ||
Model 1* | 1.77 (1.62–1.93) | <0.001 |
Model 2† | 1.25 (1.13–1.37) | <0.001 |
Model 3‡ | 1.26 (1.13–1.40) | <0.001 |
Premenopausal women | ||
Model 1* | 1.01 (0.64–1.57) | 0.976 |
Model 2† | 1.07 (0.68–1.70) | 0.765 |
Model 3§ | 1.14 (0.71–1.84) | 0.586 |
Postmenopausal women | ||
Model 1* | 1.60 (1.45–1.77) | <0.001 |
Model 2† | 1.28 (1.15–1.42) | <0.001 |
Model 3∥ | 1.27 (1.14–1.41) | <0.001 |
Odds ratios were calculated by multivariate logistic regression.
CI, confidence interval; BMI, body mass index; WC, waist circumference; DM, diabetes mellitus; CKD, chronic kidney disease.
‡ Adjusted for age, BMI, WC, hypertension, dyslipidemia, DM, CKD, thyroid disease, smoking status, alcohol consumption, physical activity, menopausal status, and hormone replacement therapy.
Association between Near Work Time and Depression among Workers in South Korea2021 September;42(5)
Association between Abdominal Obesity and Oxidative Stress in Korean Adults2019 November;40(6)